Location History:
- Redwood City, CA (US) (1997)
- Palo Alto, CA (US) (1995 - 2002)
Company Filing History:
4 out of 45 
1 out of 789 
2 out of 832,912 Years Active: 1995-2002
Title: The Innovative Contributions of James R. Dasch
Introduction
James R. Dasch is a notable inventor based in Palo Alto, California, recognized for his significant contributions to the field of biotechnology. With a total of seven patents to his name, he has made remarkable advancements, particularly in the development of monoclonal antibodies.
Latest Patents
Among his latest patents are the "Monoclonal antibodies to transforming growth factor-beta and methods of use." These monoclonal antibodies are prepared from hybrid cell lines by immunizing with TGF-B2. The antibodies can be of any isotype and may originate from various mammalian sources, including murine or human. Therapeutic applications utilizing the TGF-B monoclonal antibody are also disclosed in his work. Another patent titled "Monoclonal antibodies to transforming growth factor-beta and methods" shares similar methodologies and applications, further emphasizing his focus on TGF-B.
Career Highlights
James R. Dasch has had a distinguished career, working with prominent companies such as Celtrix Pharmaceuticals, Inc. His work has significantly impacted the biotechnology sector, particularly in therapeutic applications.
Collaborations
Throughout his career, Dasch has collaborated with notable individuals, including Doran R. Pace III and Wendy O. Waegell. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
James R. Dasch's contributions to the field of biotechnology, particularly through his patents on monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.